View all dosages and compare prices:
💊 Buy Mounjaro — all dosages →Buy Mounjaro 7.5 mg (Mounjaro 7.5 мг)
Optimal weight loss — most popular choice
in Ukraine · Original Eli Lilly (UK) · Thermobox delivery
4 injections per pen · UK version by Eli Lilly
Ships tomorrow (Wed) · before 19:00
Delivery Thu, May 14 · Nova Poshta
The most popular Mounjaro pen 7.5 mg — optimal balance of effectiveness and comfort. Recommended dose for most clients.
Найпопулярніша програма серед клієнтів DOZA. Оптимальний баланс ефективності та комфорту.
Specialist support included
A personal DOZA specialist supports you throughout the entire course — from the first consultation to results.
DOZA offers the original UK version of Mounjaro 7.5 mg
Eli Lilly and Company Limited (United Kingdom), registered by MHRA for the UK market. Not Indian generics, not the US version (FDA), not Chinese copies. You can verify authenticity by the serial number on the packaging.
Why specifically the UK version? After incidents with DE and ES supply chains — where storage conditions were compromised and clients didn't achieve expected results — we chose exclusively the British Eli Lilly supply chain. It has the strictest post-Brexit transport controls for GLP-1 products.
Free specialist consultation
Benefits of Mounjaro 7.5 мг (Mounjaro)
- ✓Most popular dose — optimal ratio of effect and comfort
- ✓Expected result: -10 to -15 kg from program start
- ✓Powerful appetite reduction without effort or diets
- ✓Recommended for long-term use
- ✓Original Eli Lilly product with verified serial number
- ✓DOZA specialist support 24/7 + delivery across Ukraine
Mounjaro 7.5 мг (Mounjaro) — detailed description
Mounjaro 7.5 mg — the most popular dose among DOZA clients. This is the optimal balance between effectiveness and comfort, at which most clients achieve the best results.
At the 7.5 mg dose, the dual GLP-1 + GIP action works at full capacity. Appetite decreases significantly — many clients note that they forget about snacks between main meals.
According to SURMOUNT-1 data, at optimal doses (7.5-10 mg) participants lost -15 to -20% of weight. DOZA clients at 7.5 mg typically achieve -10 to -15 kg from the start of the program.
It is recommended to stay at this dosage longer if the result is satisfactory — there is no need to rush with dose escalation.
How Mounjaro 7.5 mg works — tirzepatide mechanism of action
At the optimal dose of 7.5 mg, all three mechanisms of tirzepatide action work most effectively:
• Powerful appetite control: GLP-1 + GIP act on the hunger center in the hypothalamus, providing sustained reduction in desire to eat
• Active fat burning: GIP receptors stimulate the use of fat stores as the primary energy source
• Prolonged satiety: gastric transit delay provides a feeling of fullness for 6-8 hours after eating
7.5 mg is the dose at which most clients no longer experience adaptation discomfort, but the effect is maximally pronounced.
Clinical research
Mounjaro (tirzepatide7.5 mg) — FDA approved 2022. Dual GLP-1 + GIP agonist. The /research page contains the full evidence base: SURMOUNT-1 / SURPASS-2 / FDA prescribing information.
- SURMOUNT-1: Tirzepatide once weekly for the treatment of obesity (NEJM 2022)PubMed · 2022
- SURPASS-2: Tirzepatide vs semaglutide in type 2 diabetes (NEJM 2021)PubMed · 2021
- FDA prescribing information — Mounjaro (tirzepatide)FDA prescribing information · 2022
Titration protocol to 7.5 мг (тирзепатид)
Стартова доза — адаптація ШКТ
Перша терапевтична доза
Підвищення після ≥4 тижнів на 5 мг
Injection 1 раз на тиждень, subcutaneous (abdomen, thigh or upper arm). Expected weight loss at 7.5 мг: 12–14% за 40 тижнів (based on clinical studies).
Who is Mounjaro 7.5 мг for
- Пацієнти, яким 5 мг недостатньо для цільової втрати ваги
- Проміжна доза між 5 та 10 мг — дозволяє тонке налаштування
- Пацієнти з ІМТ 30–35, які потребують більшого ефекту
Mounjaro 7.5 мг — compared to other doses
- 7.5 мг — проміжний крок, не обов'язковий (можна з 5 одразу на 10)
- Побічні ефекти можуть бути слабшими ніж при стрибку 5→10 мг
- Середня втрата ваги: ~12–14% за 40 тижнів
Frequently asked questions about Mounjaro 7.5 mg
доза 7.5 мг забезпечує оптимальний баланс ефективності та комфорту. Подвійний механізм GLP-1 + GIP працює на повну потужність, але адаптація вже завершена. Більшість клієнтів DOZA досягають найкращих результатів саме на 7.5 мг.
Анастасія Шаповал
Спеціаліст з метаболічних програм та контролю ваги
Weight loss program — step-by-step dose escalation
DOZA client reviews for Mounjaro 7.5 mg
Mounjaro 7.5 mg — felt results in 3 weeks. Lost 4 kg in the first month. Thermobox delivery, excellent quality. DOZA — support throughout the entire course.
Ordering Mounjaro 7.5 mg for the second time. Original Eli Lilly quality, fair price. DOZA — highly recommend.
All Mounjaro client results →
Before/after photos · numbers · timelines · reviews
Other Mounjaro dosages
Mounjaro 7.5 mg — buy in Ukraine from DOZA
Mounjaro 7.5 mg (tirzepatide) — original KwikPen by Eli Lilly for weight loss programs. Price 21 000 ₴ (≈ 5 250 ₴ per injection). Buy Mounjaro 7.5 mg in Ukraine through the DOZA online service with delivery within 1–2 days in a thermobox (cold chain 2–8°C).
Why does DOZA only work with the UK version? We stopped working with DE and ES versions after cases when clients didn't achieve expected results — likely due to storage condition violations during transport. The UK supply chain of Eli Lilly has the strictest quality control among European markets. Each KwikPen has a serial number verifiable on the manufacturer's official website.
Mounjaro 7.5 mg is suitable for weeks 9-12 of the tirzepatide protocol. Tirzepatide works through a dual GLP-1 + GIP mechanism — reducing appetite and improving glucose metabolism. The SURMOUNT-1 clinical trial showed up to 20% weight loss over 72 weeks.
DOZA offers exclusively the Mounjaro Made in U.K. version. Mounjaro 7.5 mg delivery across Ukraine (Kyiv, Kharkiv, Odesa, Dnipro, Lviv) by Nova Poshta or courier in a thermobox. Free specialist consultation and support throughout the entire course included.
⚠️ This information is for educational purposes only and does not constitute advertising of medicinal products. We recommend obtaining an individual specialist consultation before starting a program. Results may vary depending on individual characteristics. Mounjaro® is a registered trademark of Eli Lilly and Company.
